Anzeige
Mehr »
Donnerstag, 26.03.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14M2J | ISIN: IE00BTN1Y115 | Ticker-Symbol: 2M6
Tradegate
26.03.26 | 08:46
75,89 Euro
-0,21 % -0,16
1-Jahres-Chart
MEDTRONIC PLC Chart 1 Jahr
5-Tage-Chart
MEDTRONIC PLC 5-Tage-Chart
RealtimeGeldBriefZeit
75,5676,4009:20
75,5676,4209:19

Aktuelle News zur MEDTRONIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiMedtronic cuts 2026 guidance on private equity charge related to MiniMed approval3
MiMedtronic lowers 2026 earnings outlook on recent MiniMed updates6
DiMedtronic plc - 8-K, Current Report3
DiMerit Medical stock gains exclusive distribution deal with Medtronic2
DiMerit Medical: Aktie profitiert von exklusivem Vertriebsdeal mit Medtronic2
DiMedtronic, Merit Medical ink distro deal for ViaVerte nerve ablation tech4
DiMedtronic Inks Distribution Agreement With Merit Medical Systems To Offer FDA-approved ViaVerte282DUBLIN (dpa-AFX) - Medical technology company Medtronic plc (MDT) announced Tuesday that it has entered into a distribution agreement with Merit Medical Systems, Inc. (MMSI), to offer FDA-approved...
► Artikel lesen
MEDTRONIC Aktie jetzt für 0€ handeln
DiMedtronic plc: Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain604Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain GALWAY, Ireland...
► Artikel lesen
DiMedtronic partners with Merit Medical to distribute back pain device4
MoMedtronic wins expanded FDA approval for OmniaSecure for conduction pacing4
MoMedtronic plc: Medtronic OmniaSecure defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing1.042Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc...
► Artikel lesen
MoBofA reiterates Medtronic stock rating on revenue growth outlook13
MoMedtronic Wins FDA Approval For Expanded Use Of OmniaSecure Defibrillation Lead300WASHINGTON (dpa-AFX) - Medtronic plc (MDT) said Monday it has received approval from the U.S. Food and Drug Administration for an expanded indication of its OmniaSecure defibrillation lead.The...
► Artikel lesen
MoMedtronic erhält FDA-Zulassung für Defibrillationselektrode zur Reizleitungstherapie7
MoBofA sees Medtronic stock revenue accelerating from new model5
19.03.Medtronic exec explains how Scientia acquisition boosts Neurovascular portfolio3
13.03.Needham reiterates Buy on Medtronic stock, cuts Q4 EPS view on IPO29
12.03.Medtronic plc GAAP EPS of -$1.11, revenue of $33.48M9
11.03.Medtronic auf der Leerink-Konferenz: Strategischer Wachstumskurs und operative Herausforderungen12
10.03.Medtronic auf Barclays-Konferenz: Wachstumsstrategie trotz globaler Herausforderungen14
Weiter >>
371 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,2,5